Multi-gene duplication removal in an engineered human cellular MECP2 duplication syndrome model with an IRAK1-MECP2...

Area of Science:

• Genetics and Genomics
• Cell Biology
• Disease Modeling

Background:

• Copy-number variation (CNV) diseases are prevalent but challenging to model accurately.
• Advanced genome editing technologies enable sophisticated cell model generation.
• Existing models struggle to replicate large structural variants characteristic of CNV disorders.

Purpose of the Study:

• To establish a HAP1 cell line model for methyl CpG binding protein 2 (MECP2) duplication syndrome (MDS).
• To demonstrate the utility of HAP1 cells for modeling diseases with large structural variants.
• To provide a platform for studying gene overexpression and developing therapeutic interventions for MDS.

Main Methods:

• Utilized CRISPR-Cas9 gene editing with a single-guide RNA (gRNA) strategy.
• Generated a novel cell line by excising a duplicated genomic segment in HAP1 cells.
• Focused on the duplication of MECP2 and IRAK1 genes, characteristic of MDS.

Main Results:

• Successfully created a cell line that accurately models the genomic rearrangement of MDS.
• Demonstrated a significant reduction in MECP2 and IRAK1 gene expression levels (halved).
• Validated the model's capability to recapitulate disease-specific genetic alterations.

Conclusions:

• The developed HAP1 cell line is a crucial tool for researching MECP2 duplication syndrome.
• The methodology is adaptable for modeling other CNV disorders.
• This model facilitates the testing of genomic and pharmacological interventions for CNV diseases.